- Home
- ASYS vs STRO Comparison
ASYS vs STRO Comparison
Compare ASYS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- STRO
- Stock Information
- Founded
- ASYS 1981
- STRO 2003
- Country
- ASYS United States
- STRO United States
- Employees
- ASYS N/A
- STRO N/A
- Industry
- ASYS Industrial Machinery/Components
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASYS Technology
- STRO Health Care
- Exchange
- ASYS Nasdaq
- STRO Nasdaq
- Market Cap
- ASYS 83.0M
- STRO 68.1M
- IPO Year
- ASYS N/A
- STRO 2018
- Fundamental
- Price
- ASYS $7.77
- STRO $0.86
- Analyst Decision
- ASYS
- STRO Hold
- Analyst Count
- ASYS 0
- STRO 7
- Target Price
- ASYS N/A
- STRO $1.97
- AVG Volume (30 Days)
- ASYS 403.0K
- STRO 499.5K
- Earning Date
- ASYS 08-06-2025
- STRO 11-12-2025
- Dividend Yield
- ASYS N/A
- STRO N/A
- EPS Growth
- ASYS N/A
- STRO N/A
- EPS
- ASYS N/A
- STRO N/A
- Revenue
- ASYS $83,634,000.00
- STRO $104,473,000.00
- Revenue This Year
- ASYS N/A
- STRO $65.48
- Revenue Next Year
- ASYS $12.93
- STRO N/A
- P/E Ratio
- ASYS N/A
- STRO N/A
- Revenue Growth
- ASYS N/A
- STRO N/A
- 52 Week Low
- ASYS $3.20
- STRO $0.52
- 52 Week High
- ASYS $10.80
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- ASYS 42.89
- STRO 49.15
- Support Level
- ASYS $8.76
- STRO $0.77
- Resistance Level
- ASYS $10.80
- STRO $0.89
- Average True Range (ATR)
- ASYS 0.87
- STRO 0.07
- MACD
- ASYS -0.32
- STRO -0.01
- Stochastic Oscillator
- ASYS 3.50
- STRO 38.79
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.